Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 42.3B | 48.4B | 40.6B | 39.1B |
| Cost of revenue | 7.6B | 8.8B | 7.4B | 7.3B |
| Gross profit | 34.7B | 39.5B | 33.2B | 31.8B |
| Operating expense | ||||
| Research & development | 12.2B | 12.2B | 11.2B | 10.5B |
| Selling general and admin | 5.0B | 4.0B | 4.7B | 6.4B |
| Other operating expenses | — | — | — | — |
| Operating income | 17.6B | 23.4B | 17.4B | 14.8B |
| Non operating interest income | ||||
| Income | 658M | 731M | 661M | 540M |
| Expense | 240M | 251M | 208M | 128M |
| Other income expense | 232M | -385M | 11M | -168M |
| Pretax income | 18.4B | 23.6B | 17.8B | 15.1B |
| Tax provision | 1.7B | 2.7B | 2.1B | 1.6B |
| Net income | 16.6B | 20.8B | 15.7B | 13.5B |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 22.3B | 28.6B | 22.0B | 19.0B |
| Net income from continuing op. | 16.6B | 20.8B | 15.7B | 13.5B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |